Boundless Bio Inc (BOLD)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$2.870.00%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · BOLD
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | |
|---|---|---|---|---|---|
| Operating Expenses & Income | |||||
| R&D Expenses | 44.2 | 44.8 | 55.3 | 42.6 | — |
| Operating Income | (68.0) | (63.6) | (73.3) | (54.8) | — |
| Earnings from Continuing Operations | |||||
| Interest & Investment Income | 4.0 | 5.4 | 7.9 | 5.3 | — |
| Other Non-Operating Income / Expenses | 4.0 | 5.4 | 7.9 | 5.4 | — |
| Net Income | |||||
| Net Income | (64.0) | (58.2) | (65.4) | (49.4) | — |
| Per Share | |||||
| Basic EPS | (2.85) | (2.60) | (3.85) | (40.65) | — |
| Diluted EPS | (2.85) | (2.60) | (3.85) | (40.65) | — |
| Basic Weighted Avg Shares | 22.5 | 22.4 | 17.0 | 1.2 | — |
| Diluted Weighted Avg Shares | 22.5 | 22.4 | 17.0 | 1.2 | — |
| Supplemental | |||||
| EBITDA | — | (62.3) | (72.2) | (53.8) | — |
| EBIT | (68.0) | (63.6) | (73.3) | (54.8) | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.